AMT:CA:TSV-AmeriTrust Financial Technologies Inc. (CAD)

COMMON STOCK | Others |

Last Closing

USD 0.17

Change

+0.01 (+6.25)%

Market Cap

N/A

Volume

0.12M

Analyst Target

N/A
Analyst Rating

N/A

ducovest Verdict

Verdict

About

Address: 1100 Burloak Drive, Burlington, ON, Canada, L7N 6B2

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-10-29 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
BRN-PA:CA Brookfield Investments Corpora..

N/A

USD 1.26B
FCGV:CA Florida Canyon Gold Inc.

+0.01 (+1.33%)

USD 0.07B
XGC:CA Xali Gold Corp

-0.01 (-10.00%)

USD 9.11M
PWRO:CA Power One Resources Corp.

N/A

USD 1.33M
BCHT:CA Birchtech Corp.

N/A

N/A
GHRT:CA Greenheart Gold Inc.

+0.01 (+1.33%)

N/A
LEGY:CA Legacy Gold Mines Ltd.

N/A

N/A
CNVI:CA Conavi Medical Corp.

+0.39 (+35.14%)

N/A
MIM:CA MiMedia Holdings Inc.

+0.02 (+6.82%)

N/A
AGAG:CA Argenta Silver Corp.

N/A

N/A

ETFs Containing AMT:CA

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Trailing 12 Months  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Trailing 5 Years  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Average Annual (5 Year Horizon)  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) N/A N/A N/A N/A N/A
Risk Adjusted Return N/A N/A N/A N/A N/A
Market Capitalization N/A N/A N/A N/A N/A

Annual Financials (CAD)

Quarterly Financials (CAD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:

There is nothing we particularly like

What to not like:

There is nothing we particularly dislike